OFM
Omega Fund Management Portfolio holdings
AUM
$154M
This Quarter Return
+2.12%
1 Year Return
-32.78%
3 Year Return
+82.35%
5 Year Return
+29.08%
10 Year Return
+90.46%
AUM
$891M
AUM Growth
+$891M
(+0.88%)
Cap. Flow
+$59.5M
Cap. Flow
% of AUM
6.68%
Top 10 Holdings %
Top 10 Hldgs %
87.29%
Holding
26
New
3
Increased
3
Reduced
3
Closed
–
Top Buys
| 1 |
IMGO
Imago BioSciences, Inc. Common stock
IMGO
|
$60.5M |
| 2 |
Invivyd
IVVD
|
$26.7M |
| 3 |
ICVX
Icosavax, Inc. Common Stock
ICVX
|
$12.6M |
| 4 |
ALPN
Alpine Immune Sciences, Inc. Common Stock
ALPN
|
$7.95M |
| 5 |
SYRS
Syros Pharmaceuticals, Inc. Common Stock
SYRS
|
$1.06M |
Top Sells
| 1 |
MORF
Morphic Holding, Inc. Common Stock
MORF
|
$25.6M |
| 2 |
Atea Pharmaceuticals
AVIR
|
$20.4M |
| 3 |
Replimune Group
REPL
|
$3.32M |
Sector Composition
| 1 | Healthcare | 99.45% |
| 2 | Financials | 0.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
FibroGen
FGEN
$47.8M
| $1.15M | 0.13% | 130,646 | – | – |
|